Are Wall Street Analysts Bullish on Baxter International Stock?

Valued at a market cap of $11.3 billion, Baxter International Inc. (BAX) is a global healthcare and medtech company headquartered in Deerfield, Illinois. It specializes in medical products and pharmaceuticals focused on intravenous (IV) therapy, surgical care, anesthesia, drug compounding, and connected healthcare systems. 

Shares of BAX have lagged behind the broader market over the past 52 weeks. BAX has fallen 39% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.5%. Moreover, Baxter International stock has dipped 24.7% on a YTD basis, trailing SPX's 6.1% upstick.